Fundraising Foxsymphorna.com ↗
1 known investors
Find your way into symphorna.com ↗
Sign up to see every warm intro you have to symphorna.com ↗
- Paths you didn't know you had: your email and LinkedIn already hold routes to the symphorna.com ↗ team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Symphorna is developing a therapeutic platform for multi-RNA combination medicines that deliver combined mRNAs and siRNAs alongside a predictive design loop to target multiple disease pathways at once. It focuses on complex conditions such as fibrosis, heart failure, and neurodegeneration, with lung fibrosis as its initial proving ground.
Investors · 1
Frequently asked questions
- What does symphorna.com ↗ do?
- Symphorna is developing a therapeutic platform for multi-RNA combination medicines that deliver combined mRNAs and siRNAs alongside a predictive design loop to target multiple disease pathways at once. It focuses on complex conditions such as fibrosis, heart failure, and neurodegeneration, with lung fibrosis as its initial proving ground.
- Who are symphorna.com ↗'s investors?
- symphorna.com ↗'s investors include Heartfelt Capital.